These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21375397)

  • 1. PEI-g-PEG-RGD/small interference RNA polyplex-mediated silencing of vascular endothelial growth factor receptor and its potential as an anti-angiogenic tumor therapeutic strategy.
    Kim J; Kim SW; Kim WJ
    Oligonucleotides; 2011; 21(2):101-7. PubMed ID: 21375397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis.
    Kim WJ; Yockman JW; Lee M; Jeong JH; Kim YH; Kim SW
    J Control Release; 2005 Aug; 106(1-2):224-34. PubMed ID: 15970348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice.
    Kim WJ; Yockman JW; Jeong JH; Christensen LV; Lee M; Kim YH; Kim SW
    J Control Release; 2006 Sep; 114(3):381-8. PubMed ID: 16884805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.
    Lu ZX; Liu LT; Qi XR
    Int J Nanomedicine; 2011; 6():1661-73. PubMed ID: 21904456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice.
    Wu C; Gong F; Pang P; Shen M; Zhu K; Cheng D; Liu Z; Shan H
    PLoS One; 2013; 8(6):e66416. PubMed ID: 23922634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
    Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
    Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin targeting using RGD-PEI conjugates for in vitro gene transfer.
    Kunath K; Merdan T; Hegener O; Häberlein H; Kissel T
    J Gene Med; 2003 Jul; 5(7):588-99. PubMed ID: 12825198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An angiogenic, endothelial-cell-targeted polymeric gene carrier.
    Suh W; Han SO; Yu L; Kim SW
    Mol Ther; 2002 Nov; 6(5):664-72. PubMed ID: 12409265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
    Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W
    J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
    J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA.
    Kim N; Jiang D; Jacobi AM; Lennox KA; Rose SD; Behlke MA; Salem AK
    Int J Pharm; 2012 May; 427(1):123-33. PubMed ID: 21864664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes.
    Kim SH; Lee SH; Tian H; Chen X; Park TG
    J Drug Target; 2009 May; 17(4):311-7. PubMed ID: 19242850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic RGD-polyethylene glycol-polyethylenimine for intracranial glioblastoma-targeted gene delivery.
    Zhan C; Meng Q; Li Q; Feng L; Zhu J; Lu W
    Chem Asian J; 2012 Jan; 7(1):91-6. PubMed ID: 22072592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic RGD-poly(ethylene glycol)-polyethyleneimine is more suitable for glioblastoma targeting gene transfer in vivo.
    Zhan C; Qian J; Feng L; Zhong G; Zhu J; Lu W
    J Drug Target; 2011 Aug; 19(7):573-81. PubMed ID: 21166603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery.
    Kim HA; Nam K; Kim SW
    Biomaterials; 2014 Aug; 35(26):7543-52. PubMed ID: 24894645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery.
    Lei Y; Wang J; Xie C; Wagner E; Lu W; Li Y; Wei X; Dong J; Liu M
    J Gene Med; 2013; 15(8-9):291-305. PubMed ID: 24038955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo.
    Chen Y; Lian G; Liao C; Wang W; Zeng L; Qian C; Huang K; Shuai X
    J Gastroenterol; 2013 Jul; 48(7):809-21. PubMed ID: 23179610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering biodegradable micelles of polyethylenimine-based amphiphilic block copolymers for efficient DNA and siRNA delivery.
    Wang W; Balk M; Deng Z; Wischke C; Gossen M; Behl M; Ma N; Lendlein A
    J Control Release; 2016 Nov; 242():71-79. PubMed ID: 27498020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
    Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
    J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.